Suppr超能文献

核因子κB抑制剂PDTC对Lewis肺癌小鼠血管内皮生长因子和内皮抑素表达的影响

Effect of NF- κ B inhibitor PDTC on VEGF and endostatin expression of mice with Lewis lung cancer.

作者信息

Gao Ping, Gao Ya-Jie, Liang Hong-Lu

机构信息

Oncology Department, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000, China.

Oncology Department, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000, China.

出版信息

Asian Pac J Trop Med. 2015 Mar;8(3):220-4. doi: 10.1016/S1995-7645(14)60319-9.

Abstract

OBJECTIVE

To investigate the effects of NF- κ B inhibitor pyrrolidine dithiocarbamate hydrochloride (PDTC) on vascular endothelial growth factor (VEGF) and endostatin expression in mice with Lewis lung cance; and its mechanism.

METHODS

Mice survival rate and anti-tumor effects were observed in different concentrations of NF- κ B inhibitor PDTC after the Lewis lung cancer mice model was established. VEGF and endostatin expressions were detected by immunohistochemical assay.

RESULTS

Lewis lung cancer was be inhibited by 0.5 mg/kg, 1.5 mg/kg and 3.0 mg/kg of NF- κ B inhibitor PDTC (P<0.05). Microvessel density (MVD) in 0.5 mg/kg, 1.5 mg/kg and 3.0 mg/kg NF- κ B inhibitor PDTC groups were significantly lower than the control group (P<0.05). Immunohistochemical assay results showed that VEGF and endostatin expressions in the 0.5 mg/kg, 1.5 mg/kg and 3.0 mg/kg NF-κ B inhibitor PDTC groups were significantly lower than the control group (P<0.05). Western blot results also showed that NF- κ B inhibitor PDTC could inhibit VEGF and endostatin expressions in tumor tissues.

CONCLUSIONS

NF- κ B inhibitor PDTC can inhibit tumor formation and reduce tumor angiogenesis in mice with Lewis lung cancer; and its mechanism maybe associated to VEGF and endostatin down-regulation.

摘要

目的

探讨核因子κB(NF-κB)抑制剂盐酸吡咯烷二硫代氨基甲酸盐(PDTC)对Lewis肺癌小鼠血管内皮生长因子(VEGF)和内皮抑素表达的影响及其机制。

方法

建立Lewis肺癌小鼠模型后,观察不同浓度的NF-κB抑制剂PDTC对小鼠生存率和抗肿瘤作用的影响。采用免疫组织化学法检测VEGF和内皮抑素的表达。

结果

0.5mg/kg、1.5mg/kg和3.0mg/kg的NF-κB抑制剂PDTC可抑制Lewis肺癌生长(P<0.05)。0.5mg/kg、1.5mg/kg和3.0mg/kg NF-κB抑制剂PDTC组的微血管密度(MVD)显著低于对照组(P<0.05)。免疫组织化学检测结果显示,0.5mg/kg、1.5mg/kg和3.0mg/kg NF-κB抑制剂PDTC组的VEGF和内皮抑素表达显著低于对照组(P<0.05)。蛋白质印迹法结果也显示,NF-κB抑制剂PDTC可抑制肿瘤组织中VEGF和内皮抑素的表达。

结论

NF-κB抑制剂PDTC可抑制Lewis肺癌小鼠肿瘤形成并减少肿瘤血管生成;其机制可能与下调VEGF和内皮抑素有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验